Under construction – not a live service
Sign in
Not yet taking people in GuadeloupeNo phase

How Common Helicobacter Pylori Is in People With Crohn's Disease or Ulcerative Colitis

Looks for Helicobacter pylori in the stomachs of adults with inflammatory bowel disease.

Plain-language title generated from the registry record
Registry title: Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe

Key facts

Where
Pointe-à-Pitre, GuadeloupeSee the site

Where in Guadeloupe

  • CHU de la GuadeloupePointe-à-Pitre, GuadeloupeNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier Universitaire de la Guadeloupe
Trial code
NCT07292454
Record updated
18 December 2025
Original description
Clinical and experimental data suggest that dysbiosis may play a pivotal role in the pathogenesis of intestinal bowel disease (IBD). However, to the best of our knowledge, the composition of gastric and of intestinal microbiome has never been investigated in a population with IBD according to the presence/absence of Helicobacter pylori (H. pylori) in the stomach.Read full original descriptionShow less

Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe

Clinical and experimental data suggest that dysbiosis may play a pivotal role in the pathogenesis of intestinal bowel disease (IBD). However, to the best of our knowledge, the composition of gastric and of intestinal microbiome has never been investigated in a population with IBD according to the presence/absence of Helicobacter pylori (H. pylori) in the stomach.

Inclusion: Patients over 18 years old Patients with IBD from the CHU of Guadeloupe Patients benefiting from an investigation of H. pylori infection through gastric biopsies and/or serology at the time of diagnosis of IBD Patients affiliated to the French social security system Free informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion: Patients of less than18 years Patients having not given their writing informed consent.

ClinicalTrials.gov NCT07292454